Seeking Alpha

Athersys, Inc. (ATHX)

()

Market Currents

  • Monday, December 21, 2009

  • 09:48 AM Athersys (ATHX) +200% after inking a deal with Pfizer (PFE) to develop and market its experimental stem cell therapy MultiStem. Pfizer will pay $6M up front, fund the drug's R&D, and pay up to $105M on milestones. Comment!